- Home
- PRAX vs BRBR Comparison
PRAX vs BRBR Comparison
Compare PRAX & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- BRBR
- Stock Information
- Founded
- PRAX 2015
- BRBR 2019
- Country
- PRAX United States
- BRBR United States
- Employees
- PRAX N/A
- BRBR N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- BRBR Packaged Foods
- Sector
- PRAX Health Care
- BRBR Consumer Staples
- Exchange
- PRAX Nasdaq
- BRBR Nasdaq
- Market Cap
- PRAX 4.0B
- BRBR 3.7B
- IPO Year
- PRAX 2020
- BRBR 2019
- Fundamental
- Price
- PRAX $179.18
- BRBR $26.96
- Analyst Decision
- PRAX Strong Buy
- BRBR Buy
- Analyst Count
- PRAX 12
- BRBR 18
- Target Price
- PRAX $212.42
- BRBR $59.72
- AVG Volume (30 Days)
- PRAX 978.5K
- BRBR 3.0M
- Earning Date
- PRAX 11-05-2025
- BRBR 11-18-2025
- Dividend Yield
- PRAX N/A
- BRBR N/A
- EPS Growth
- PRAX N/A
- BRBR 5.53
- EPS
- PRAX N/A
- BRBR 1.75
- Revenue
- PRAX $7,463,000.00
- BRBR $2,224,200,000.00
- Revenue This Year
- PRAX N/A
- BRBR $17.62
- Revenue Next Year
- PRAX $44.43
- BRBR $9.54
- P/E Ratio
- PRAX N/A
- BRBR $15.38
- Revenue Growth
- PRAX 364.98
- BRBR 16.27
- 52 Week Low
- PRAX $26.70
- BRBR $26.83
- 52 Week High
- PRAX $206.71
- BRBR $80.67
- Technical
- Relative Strength Index (RSI)
- PRAX 62.04
- BRBR 18.32
- Support Level
- PRAX $159.74
- BRBR $27.52
- Resistance Level
- PRAX $188.53
- BRBR $29.35
- Average True Range (ATR)
- PRAX 13.41
- BRBR 1.10
- MACD
- PRAX -5.00
- BRBR -0.20
- Stochastic Oscillator
- PRAX 47.30
- BRBR 1.24
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.